Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0470
+0.0040 (9.30%)
Apr 29, 2026, 3:45 PM AEST
17.50%
Market Cap 20.52M
Revenue (ttm) 13.84M
Net Income (ttm) 769.30K
Shares Out 477.12M
EPS (ttm) 0.00
PE Ratio 26.43
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,509,994
Average Volume 346,654
Open 0.0430
Previous Close 0.0430
Day's Range 0.0430 - 0.0470
52-Week Range 0.0330 - 0.0590
Beta 1.07
RSI 53.66
Earnings Date May 27, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.